Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Meredith B Brooks, Ph.D.

Co-Author

This page shows the publications co-authored by Meredith Brooks and Leonid Lecca.
Connection Strength

1.335
  1. Mapping local hot spots with routine tuberculosis data: A pragmatic approach to identify spatial variability. PLoS One. 2022; 17(3):e0265826.
    View in: PubMed
    Score: 0.248
  2. A role for community-level socioeconomic indicators in targeting tuberculosis screening interventions. Sci Rep. 2022 01 17; 12(1):781.
    View in: PubMed
    Score: 0.245
  3. Prediction Tool to Identify Children at Highest Risk of Tuberculosis Disease Progression Among Those Exposed at Home. Open Forum Infect Dis. 2021 Nov; 8(11):ofab487.
    View in: PubMed
    Score: 0.243
  4. Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis". Antimicrob Agents Chemother. 2017 09; 61(9).
    View in: PubMed
    Score: 0.090
  5. Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis. Antimicrob Agents Chemother. 2017 08; 61(8).
    View in: PubMed
    Score: 0.090
  6. Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial. BMC Infect Dis. 2016 08 27; 16(1):453.
    View in: PubMed
    Score: 0.084
  7. A structured community engagement strategy to support uptake of TB active case-finding. Public Health Action. 2022 Mar 21; 12(1):18-23.
    View in: PubMed
    Score: 0.062
  8. Identifying barriers and facilitators to implementation of community-based tuberculosis active case finding with mobile X-ray units in Lima, Peru: a RE-AIM evaluation. BMJ Open. 2021 07 07; 11(7):e050314.
    View in: PubMed
    Score: 0.059
  9. Closing delivery gaps in the treatment of tuberculosis infection: Lessons from implementation research in Peru. PLoS One. 2021; 16(2):e0247411.
    View in: PubMed
    Score: 0.058
  10. Tuberculosis clinical presentation and treatment outcomes in pregnancy: a prospective cohort study. BMC Infect Dis. 2020 Sep 18; 20(1):686.
    View in: PubMed
    Score: 0.056
  11. Reply to te Brake et al.: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis. Am J Respir Crit Care Med. 2019 05 01; 199(9):1167-1168.
    View in: PubMed
    Score: 0.051
  12. Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial. Am J Respir Crit Care Med. 2018 09 01; 198(5):657-666.
    View in: PubMed
    Score: 0.049
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.